ES2083387T3 - Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv. - Google Patents

Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.

Info

Publication number
ES2083387T3
ES2083387T3 ES89400221T ES89400221T ES2083387T3 ES 2083387 T3 ES2083387 T3 ES 2083387T3 ES 89400221 T ES89400221 T ES 89400221T ES 89400221 T ES89400221 T ES 89400221T ES 2083387 T3 ES2083387 T3 ES 2083387T3
Authority
ES
Spain
Prior art keywords
amino acid
hiv
begins
peptides
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89400221T
Other languages
English (en)
Other versions
ES2083387T5 (es
Inventor
Francesco Bellini
Gervais Dionne
Martial Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Biochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27386744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2083387(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/148,821 external-priority patent/US6218102B1/en
Priority claimed from US07/281,205 external-priority patent/US6214537B1/en
Application filed by IAF BioChem International Inc, Biochem Pharma Inc filed Critical IAF BioChem International Inc
Publication of ES2083387T3 publication Critical patent/ES2083387T3/es
Application granted granted Critical
Publication of ES2083387T5 publication Critical patent/ES2083387T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PROPORCIONAN PEPTIDOS CICLCOS DE FORMULA(I), EN LA QUE X ES EL EXTREMO AMINO, UN AMINOACIDO O SECUENCIA DE AMINOACIDO QUE EMPIEZA CON EL AMONOACIDO 604 Y LLEGA HASTA EL AMINOACIDO 586 (GP 41 - HIV - 1); E Y ES EL EXTREMO CARBOXILICO, UN AMINOACIDO O SECUENCIA AMINOACIDO QUE EMPIEZA CON EL AMINOACIDO 612 Y LLEGA HASTA EL AMINOACIDO 629 (GP 41 HIV - 1). TAMBIEN SE PROPORCIONAN PEPTIDOS DE FORMULA(II) EN LA QUE X1 ES EL EXTREMO AMINO, UN AMINOACIDO O SECUENCIA AMINOACIDO QUE EMPIEZA CON EL AMINOACIDO 596 Y LLEGA AL AMINOACIDO 578 (GP 42 - HIV - 2); E Y1 ES EL EXTREMO CARBOXILICO, UN AMINOACIDO O SECUENCIA AMINOACIDO QUE EMPIEZA CON EL AMINOACIDO 604 Y LLEGA HASTA EL 613 (GP 42 - HIV - 2). ESTOS PEPTIDOS CICLICOS SOLOS O EN MEZCLA CON DETERMINADOS PEPTIDOS LINEALES SON PARTICULARMENTE UTILES PARA LA DETECCION DE ANTICUERPOS.
ES89400221T 1988-01-27 1989-01-26 Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv. Expired - Lifetime ES2083387T5 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/148,821 US6218102B1 (en) 1988-01-27 1988-01-27 Synthetic peptides and mixtures thereof for detecting HIV antibodies
US18551888A 1988-04-22 1988-04-22
US185518 1988-12-07
US148821 1988-12-07
US281205 1988-12-07
US07/281,205 US6214537B1 (en) 1988-01-27 1988-12-08 Synthetic peptides and mixtures thereof for detecting HIV antibodies

Publications (2)

Publication Number Publication Date
ES2083387T3 true ES2083387T3 (es) 1996-04-16
ES2083387T5 ES2083387T5 (es) 2005-07-01

Family

ID=27386744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89400221T Expired - Lifetime ES2083387T5 (es) 1988-01-27 1989-01-26 Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.

Country Status (7)

Country Link
EP (1) EP0326490B2 (es)
JP (3) JPH01224397A (es)
AT (1) ATE131492T1 (es)
AU (1) AU629528B2 (es)
DE (1) DE68925043T3 (es)
ES (1) ES2083387T5 (es)
IL (1) IL88963A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
GB8828097D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
GB8828098D0 (en) * 1988-12-01 1989-01-05 Wellcome Found Peptides
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
AU7676891A (en) * 1990-04-03 1991-10-30 Genentech Inc. Hiv envelope polypeptides
NZ243636A (en) * 1991-07-29 1993-06-25 Iaf Biochem Int Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
ES2287969T3 (es) * 1992-03-06 2007-12-16 Innogenetics N.V. Peptidos de vih.
CA2202408C (fr) * 1994-10-20 2012-03-06 Pierre Charneau Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o
FR2874017B1 (fr) * 2004-08-06 2006-11-24 Bio Rad Pasteur Sa Peptides vih-1 modifies et leur utilisation en detection d'anticorps anti-vih
EP2778681A1 (en) * 2013-03-15 2014-09-17 Biomay Ag Method for diagnosing a viral infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
EP0247557B1 (en) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV) Envelope peptides
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
EP0309566B1 (en) * 1987-04-16 1994-01-12 Johnson And Johnson Stlv-iii-related polypeptides, diagnostic systems and assay methods
JPH0215098A (ja) * 1987-05-18 1990-01-18 Virovahl Sa Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits

Also Published As

Publication number Publication date
AU629528B2 (en) 1992-10-08
DE68925043T2 (de) 1996-08-22
ATE131492T1 (de) 1995-12-15
IL88963A0 (en) 1989-08-15
EP0326490B1 (en) 1995-12-13
DE68925043D1 (de) 1996-01-25
JPH08245693A (ja) 1996-09-24
JP3851761B2 (ja) 2006-11-29
EP0326490A2 (en) 1989-08-02
AU2851389A (en) 1989-07-27
EP0326490B2 (en) 2004-11-24
EP0326490A3 (en) 1990-07-04
DE68925043T3 (de) 2005-07-28
ES2083387T5 (es) 2005-07-01
IL88963A (en) 1996-05-14
JPH01224397A (ja) 1989-09-07
JP2001055400A (ja) 2001-02-27

Similar Documents

Publication Publication Date Title
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES8705467A1 (es) Un procedimiento para producir la proteina apoacuorina
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
DE68909345D1 (de) Verfahren und Kompositionen zur Erzeugung verstärkter Chemilumineszenz von 1,2-Dioxetanen.
AR004668A1 (es) Un acido nucleico aislado purificado, un vector de expresion recombinante que lo comprende, una celula que comprende dicho vector, un metodo para laproduccion de un polipeptido de h.pylori, una composicion de vacuna, el uso de dicha composicion para preparar medicamentos, un polipeptido purificado de h.
ATE142789T1 (de) Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür
KR890000517A (ko) 하이브리드 단백질 c 및 이의 제조방법
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
DE3865963D1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
ES2060654T3 (es) Trigramina - un polipeptido inhibidor de la agregacion plaquetaria.
EA200300678A1 (ru) Пептиды и/или белки, а также их применение для получения терапевтической и/или профилактической фармацевтической композиции
DK0498784T3 (da) Hæmmere af retroviral protease
ES2098359T3 (es) Peptidos sinteticos y sus mezclas para detectar anticuerpos contra hiv.
ES2185628T3 (es) Procedimiento para preparar proteinas modificadas.
IL88963A0 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
DE3884316D1 (de) Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung.
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
ATE133993T1 (de) Protein-antikrebsmittel
MX9304388A (es) Polopeptido sintetico y proceso para su fabricacion.
NO904129D0 (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.
ATE109468T1 (de) Verbindungen zur einführung einer sh-gruppe in tyrosin.
ES8501365A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
ATE20669T1 (de) Antigene lineare peptidverbindungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 326490

Country of ref document: ES